sMadCam-1 associations with the gut microbiome in NSCLC cancer patients
This project investigated gut microbiome associations with serum sMAdCAM-1 at diagnosis in two independent cohorts of patients with advanced NSCLC treated with anti-PD-1/PD-L1 antibodies with or without chemotherapy in France and Canada.